DOI: 10.12890/2024_004801
Dacryoadenitis as a rare initial presentation in a patient with suspected CREST syndrome
Authors
arkajasingh23@gmail.com
Keywords
Systemic sclerosis, CREST syndrome, orbital inflammation, dacryoadenitis, ocular manifestationsAbstract
Systemic sclerosis (SSc) is a rare, chronic disease with diverse clinical presentations, and only a few cases with ocular manifestations have been reported in the literature. In this case report, we describe the case of a 51-year-old South Asian woman who initially complained of painless swelling in her left upper eyelid. An ultrasound examination of the left eye revealed an enlarged lacrimal gland with increased vascularity. The presence of dacryoadenitis, which was unresponsive to initial conservative management with oral antibiotics and warm compresses, along with positive antinuclear antibodies, prompted further investigation. Dacryoadenitis or orbital inflammation is a common presentation in systemic conditions such as Sjogren’s syndrome, systemic lupus erythematosus, sarcoidosis, or granulomatosis with polyangiitis. However, it can also be a rare initial symptom in a patient with CREST syndrome. To our knowledge, this is only the second case in the literature of dacryoadenitis in the context of calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) syndrome. This case highlights the significance of serological markers and peripheral clinical presentations in individuals with chronic orbital inflammation, emphasizing the importance of considering further systemic associations.
References
- Bukiri H, Volkmann ER. Current advances in the treatment of systemic sclerosis. Curr Opin Pharmacol 2022;64:102211.
- Rosendahl AH, Schönborn K, Krieg T. Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung J Med Sci 2022;38:187-195.
- LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-1576.
- Volkmann ER, Andréasson K, Smith V. Systemic sclerosis. Lancet 2023;401:304-318.
- Jakhar D, Grover C, Singal A, Das GK. Nailfold Capillaroscopy and Retinal Findings in Patients with Systemic Sclerosis: Is There An Association? Indian Dermatol Online J 2020;11:382-386.
- Szucs G, Szekanecz Z, Aszalos Z, Gesztelyi R, Zsuga J, Szodoray P et al. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis. Ocul Immunol Inflamm 2021;29:81-89.
- Saifi M, Odeh A, Abuzahra S, Younis O, Shanti Y. Bilateral Dacryoadenitis As the First Presentation in an Undiagnosed Sarcoidosis Patient. Cureus 2023;15:e48287.
- Hamed-Azzam SW, D’Cruz DP, Verity DH. Orbital Inflammation as a Presenting Sign for CREST Syndrome. Ophthalmic Plast Reconstr Surg 2018;34:e43-e45.
- Mchugh NJ. “20 - Centromere Autoantibodies.” In Autoantibodies (Second Edition), edited by Yehuda Shoenfeld, M. Eric Gershwin, and Pier Luigi Meroni, Second Edition., 151–57. Burlington: Elsevier, 2007.
- Kajio N, Takeshita M, Suzuki K, Kaneda Y, Yamane H, Ikeura K et al. Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling. Ann Rheum Dis 2021;80:651-659.
- Birtane M, Yavuz S, Tastekin N. Laboratory evaluation in rheumatic diseases. World J Methodol 2017;7:1-8.
- van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-2747.
- Kozikowska M, Lubon W, Kucharz EJ, Mrukwa-Kominek E. Ocular manifestations in patients with systemic sclerosis. Reumatologia 2020;58:401-406.
- Waszczykowska A, Gos R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P. Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci 2013;9:1107-1113.
